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THE EFFECT OF ORAL AND TOPICAL TETRACYCLINE ON ACNE SEVERITY 
AND ON SURFACE LIPID COMPOSITION 
ROBERT L. ANDERSON, PH.D., CYRIL H . COOK. M.S., AND DONALD E. SMITH-
The Procter & Gamble Company, Miami Valley Laboratories, Cincinnati , Ohio, U.S.A. 
Groups of 20 males of high-school age with moderate acne were t reated with oral tetracy-
cline (500 mg/day). topica l tetracycline (0.5% solution applied twice daily). or placebo for 8 
weeks. The two panels t reated with tetracycline showed a significant and equivalent reduc-
t ion in acne sever ity as assessed by visual grading. 
The surface lipids in the panel treated with oral tetracycline showed a small but n Ol 
statistically significant decrease in free fauy acid content. but the subjects receiving topical 
tetracycline showed no reduction in free fauy acids. Further, neither treatment was 
associated with a change in mass of surface lipid nor did the mass or weight percent of any 
component of the surface lipids change with the decrease in acne severity. These results show 
that acne sever ity can be reduced with tetracycline (both oral and topical) without any 
concomitant quantitath'e change in surface lipids. 
Skin surface lipids have been studied extensively 
in attempts to define their role in the etiology ~f 
acne. The component of skin surface lipid most 
frequently implicated as a causative agent in acne 
is the free fatty acid (FFA ) fraction. Several 
workers have attempted to establish a correlat ion 
between skin surface lipid FFA content and acne 
severity with resul ts that are quite va riable. For 
example. Powell and Beveridge 111 and Runkel et 
al 12) were unable to detect any difference in FF' A 
concentrations in skin lipids from acne patients 
and age peers without acne. Gloor et al 13) have 
reported lower FFA levels in lipids from the backs 
of teen-agers with severe acne than from subject.s 
with moderate or mild acne. In contrast. Nicol~ 
aides et al 14) have shown that comedo lipids ha\'e 
a higher FFA content than do surface lipids at the 
same site. and Nicolaides et al 151 and Anderson et 
81 [6) have shown that foll icular lipid, contain 
more FFA than surface lipids from the same site. 
In addition to measuring the FF A content of 
surface lipids. investigators have attempted t.o 
demonstrate that medicat ions which improve acne 
do reduce the FFA concentrations in surface lipids . 
Beveridge and Powell 17J, for example. have reo 
ported that oral tetracycline causes a 50% decrease 
in surfa ce lipid FFA levels in acne patients. Mar-
ples et al 18) obtained similar results with scalp 
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lipids of some subjects given oral demethylc hlor-
tetracycline, and Kraus [9J showed that tetraey· 
cline applied topically in dirnethylacetamide re -
duced the F'FA content of su rface lipids. Recently 
Fulton [101 reported that several antibiotics ap-
plied topically (2 % in cream) can reduce surfa ce 
lipid FF Alfatty ester ratio and can also reduce 
acne severity, and Gloor et 81 [111 have presented 
evidence that 5~ tetracycli ne applied topically can 
reduce the FFA/ triglyceride ratio in surface lipids 
of acne pat.ients. In addition, it has been shown 
that /i-naphthol can reduce surface FFA levels 
112). In contrast. Gloor et al 113\ showed an 
insignifi cant reduction in FFA concent rat ions in 
the lipids from the backs of subjects treated wit h 
100 mg tetracycline per day. but did see a signifi-
cant reduction with 1000 mg tetracycline per day. 
In the above-cited work, onl~' that of Beveridge 
and Powell [7\ and Gloor et al 111,13J examined 
the effects of tetracycline in subjects with acne and 
attempted lO correlate changes in FFA levels with 
improvement in acne. The present work was un -
dertaken in order to assess the effects of topically 
applied tetracycline and oral tetracycline on sur-
face lipid composi tion and improvement in acne. 
MATERIALS AND METHODS 
Sixty males of high-school age. with acne of moderate 
severity, were divided randomly into three groups of 20. 
All subjects were exam ined weekly for 12 consecutive 
weeks. Three judges graded each subject according 1.0 the 
following procedure: 
1. Pustules were counted between the hairline and the 
mandibular ridge from ear to ear (butterfly area). 
2. A grade from 0 to 9 (none to ~\'ere) wa.s assigned 
individually for comedones. papules. and macules based 
on an estimate of the fraction of the area affected by each 
of these lesions. 
3. An overall grade from 0 to 8 (none to severeJ was 
assigned. This grade was designed to correspond to the 
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impression 8 subject would make on meeting a stranger 
at 8 distance 0(2 112 meLers. The graders we re trained with 
8 set of standard phoLOgraphs selected to make the 
severity scale linear . 
The subjects were prescreened and no subject with 
cystic acne or 8 severity grade of less than 3 was included 
in this tesl. The grades assigned to each subject at each 
gradi\lg session were averaged and analyzed by the 
analysis of va riance method . In this report we wiil present 
only the severity grades since they reflect the overall 
change in acne. It should be noted that both oral and 
topical tetracycline produced comparable changes in the 
individual les ion types . That is . t hese t reatments pro-
duced a statistically significant reduction in pustules and 
papu les but a nonsignifi cant decrease in comedones and 
macules. 
Twice du ring the four weeks prior to the initiation of 
t reatment, surface lipids of each subject were collected 
by the following method : a fla t. glass ext raction vessel. 
17 .5 cm J in area, resembling a Petri dish with II neck for 
solvent addition and a stopcock for draining. was placed 
against the right cheek. About 10 ml of diethyl ether was 
introduced into the vessel through the glass tube at the 
top. The e the r remained in contact with the skin for 30 
sec after which it was drained through the stopcock into a 
tared weighing bottle. The vessel was immediately re -
filled, and after 30 sec. drained into the same weighing 
bottle. This sample was blown to d ryness under a st ream 
of Nt. The residue was suspended in chloroform ( -5 mI). 
centrifuged to separate solids. decanted. and again evap-
orated to dryness under Nt. The lipid residue was 
weighed. 
At the end of the 4th week. the members of each panel 
began an 8-week treatment program as follows: 
Panel I: T he butterny surface of the face was treated 
with a roll-on applicator daily with a 0.5% solution of 
tetracycline Hel in 30:70 ethanol:water (vol/vol) with 
0.5gf C1oMSO and 0.25Of SMO. Each subject was given a 
250-mg gelatin capsule of lactose twice daily . 
Panel II: The butterny surface of the face was ueated 
twice dailv with 30:70 elhanol:w8ler solution. Each 
subject wa~ given a 250-mg gelatin capsule of tetracy-
cline Hel twice daily . 
Panel Ill: The butterfly surface of the face was treated 
twice dailv with aO:70 ethanol:water solution. Each 
subject was given a 250-mg gelatin capsule of lactose 
twice daily . 
The lactose and tetracycline capsules were indistin-
guishable from one a nother. The topical placebo con -
tained a ve~elable dye (FD&C #5) to give a color simila r 
to the tetracycline HCI solution. Neither the subjects or 
the graders were aware of the treatment assignments . 
Following the procedure outlined above. surface lipids 
were collected fou r more times from each subject at 
14-day in tervals during the treat.ment period . No treat -
ments we re applied on the morning when lipid samples 
were to be obtained . 
The second cont rol pe riod sample and the second and 
fourth treatment period samples from each subject were 
analyzed fo r weight per<:en t FFA 114 J and weight percent 
t riglyceride 115J on an au toanalyzer. Only data from 
subjects present at bOlh of the lipid sampling periods are 
included in th is report. 
The effects of the t reatments on the lipid parameters 
(mass of lipid. weight percent of FF A. we ight percent of 
TG. and mass of FFA) we re evaluated by the analysis of 
variance method [16]. and all possible correlations be· 
tween lipid values and acne severity were determined 
/161 · 
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Semiquantitative analysis of the composiiton of the 
surface lipids was accomplished by a modification of the 
thin-layer chromatography (TLC) technique described 
by Anderson el al 16]. In order to assess the content of 
five components in surface lipids, the TLC plates were 
successively developed in three solvent systems: (I) 
heptane to top of the plate. (2) benzene:hexane (80:20) to 
top of the plate. (3) hexane:ether:formic acid (70:30:2.5) 
to 7 cm from the origin . Development was followed by 
charr ing. and densitometer scanning as described [6] . 
The data 8re reported as uncorrected area percent fo r 
each lipid component. 
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FIG. 1. Acne severity grades as a function of treatment 
time. First fou r points are the 8\'erage of all subjects and 
remainder of points a re the indi"idual t reatment group 
averages. The treatments used and grading technique are 
described in Mar erial$ and M ethods. 
T ABLE I. Effect 0/ oral and topical tetracycline r rear m('nt 
on acne ImproLlemenr 
Treatment 
Placebo (l"j)~ 
Oral tetracycl ine (18) 
Topical tetracycline (191 
Change in acne severity· 
> 1 l'nit <; 1 1'\0 chan~e 
decrea::e Decrea::e or incrl"a::e 
6 4 7 
12 I 5 
14 3 2 
G Pret reat ment ~rade minus final f:,! rade after 8 weeks of 
treat ment 
Ito Number in parentheses is number of subjects in each 
panel sampled for lipid analyses and acne grading at 
both the pretreatment time and after 8 weeks of treal · 
ment 
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RESULTS 
T o justify an assessment of the effects of acne 
therapies on skin surface lipid changes tha t may 
accompany alleviation of acne severit y. it is essen-
tial to establish that the t realments employed do 
indeed decrease acne severity_ Figu re 1 depi cts the 
changes in acne severity obtained with oral and 
topical tetracycline as a function of treatment time. 
compared with changes in a control group. All of 
the groups showed a decrease in severity with 
treatment, but the subjects treated with tet racy-
cline (either oral or topical) showed more tha n 
twice the improvement attained in the group 
TABLE n. Su rface lipid and severity gradel~ in subjeds 
treated u,ith ora l Dr topical tel ro cvcline 
T reatment 
Parameter Placebo Oral Topical 
(17)0 118) ( 19J 
Acne severi ty 
Pretrea lment b 3.n ~O.2f{ 3.72±0.28 3.68xO .29 
Post -t real menr'" 3.22 : 0.35 2.78±OAO 2.60±O.28 
Change" - 0.56 ± 0.31 - O.97±O.15 - 1.08",0.29 
Lipid mass 
(mg/ 17.2 cm 21 
Pretreatment 3.16::1::0.21 3.26 ~O.26 3.60 : 0.80 
Post -t reatment 3.6B~O .-1 5 3.22 ± O.24 3.36::1::0.')4 
Change - 0.43±OA6 - 0.OhO.18 -O.24:::t:O.23 
Wei~hl ~ FFA 
Pret reatment 12.9:::t:2 .2 16 - ?- 13.3, 1.3 .:>±_.I I 
Post -t reatment 12.9±1.8 12.0±. 1.2 12.1.:r.:1.3 
Change -0.O3±0.05 - 4.5 ::r. 2.2 - 1.2 ::r:. l.0 
Mg FFA/ 17.2 cm 2 
Pretreatment 0.42 : 0.09 0.54 .:t. (l. 10 0.46",,0.05 
Post -treatment 0.45 = 0.08 0.40:0.06 O.40:::t:O.05 
Change TO.o:J::r:0.05 ~ O . 14±O.07 0.07 , 0.05 
a Number in parentheses is number of !Subjects 
o Average of values obtai ned durin~ weeks 3 and -t of 
the prel reat ment pe riod 
C Each value is the mean :±. standard er ror of the mean 
for the number of subjects indicated 
'" Average of values obtai ned after 8 weeks of treatment 
.. Mean :::: SEM for individual c hangeR. pretreatment 
minus post·treatment \'alues 
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treated with both the oral placebo a nd the topical 
placebo ( .... 1.2 severity units vs .... 0.5 severity 
uni ts). The decrease in severity grade in treatment 
groups was statistically significant from week 7 to 
the end of the study. There was no stat.istically sig-
nificant difference in changes obtai ned with topi-
cal and oral tet racycl ine therapy. 
The number of subjects on each panel who 
showed a decrease in acne severity (> 1 unit ), a 
slight decrease in severit y «1 unit). a nd no change 
or an increase in sever ity is presented in Table I. 
These data show t hat. -67% of the subjects treated 
with oral tet racycline (12/18) and -74% of the sub-
jects treated with topical tetracyciine (14/19) 
showed a decrease in severit y (> 1 grade un it) com-
pared to only - 35 '1< of the subjects in the placebo 
group (6/ 17) . 
The surface lipid mass. and free fatty acid (FF A) 
concent rations before t reatment and after 8 weeks 
of treatment are presented in Table Il a long with 
the corresponding changes in acne severity grades. 
The weight percent and mass of FFA in the surface 
lipids in the placebo panel did not change. The sub-
jects trea ted with both oralletracyciine and topical 
tetracycl ine showed a decrease in FFA levels (both 
weight percent and mass). This decrease. however, 
was not statist ically significa nt. Table [] also shows 
that all groups h ad essentially the same mean 
weight percent and mass per un it a rea of FF' A aft.er 
8 weeks of treatment and that the changes induced 
with tetracycline were a function of pretreat.ment 
mean differences and not post-treatment mean dif-
fe ren ces. Thus, in this study. treatment wit.h te tra-
cycline (either oral or topical) did not indu ce a 
statistically significant change in surface lipid 
weight percent or mass per unit a rea of FFA. but 
both treatments did produce a significan t reduction 
in acne severity. Further. acne severity changes 
were not associated with cha nges in surface lipid 
mass (Tab Ill . 
Since two recent publi cations jIO,JI J have 
reported that topi cal antibiotic ca uses a decrease 
in the surface lipid FF A/esler ralio [10 J and 
FFAltriglyceride (TG) ralio [II J. we have made 
a simila r com parison (Tab. III). The FFA(fG ratio 
was lower in all three groups after 8 weeks of trea t-
ment than before treatment. The decrease ob-
TABLE lll . Surface lipid free fatt."\' ccidltripiyceride IFFA ITG) mtiOs 
Pretreatmentb 
Post -treatment'" 
Changed 
Correlation coefficient between acne change and 
FFArrG ratio change 
a Number in parentheses is number of subjec ts 
~ Mean "" SEM before t reatment began 
( M ean .::r: SEM afte r 8 weeks of therapy' 
Placebo (17)~ 
0.294 ± 0.068 
0.281 ± 0.057 
TO.01 3 ± 0.026 
0.121 
Treatment 
Oral (181 
OA08 ± 0.094 
0 .245 ± 0.038 
-0. 16:1 ± 0.063 
- 0.060 
d Mea.n ± SEM fo r individual changes pretreatment minus pORt -treatment va lues 
Topical (19) 
0.271 : 0.033 
0.241 ~ 0.039 
+ 0.030 ", 0.027 
0.073 
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served in the group treated wi th oral tetracycline 
was the decrease that was statisticaJJy significant 
(p < 0.05). It should be noted that the post-treat-
ment FFArrC ratios were approximately the same 
in all th ree groups and that the significant decrease 
observed in the group treated with oral tetracycline 
was a function of its higher pretreatment ratio and 
TABLE IV . Change ... in FFA in surface lipids in s ubje('t.~ 
selected for change in acne .'Ieuerity 
Change in severity" 
Parameter 
> 1 < I N~ chanJ!;e 
Decrease Decrease or Increase 
N umber of subjects 32 8 14 
Wt ~ FFAO - 2.0 ~ 1.0 - O.8 ± 1.5 - 2.4.::!:2.0 
mg FFA/ 17.2 em" - 0.07 x-O.04 - O.ObO.05 - O.O8 ~ O.07 
a Change in acne severity in all subjects; cha nge in 
acne between second grading and final grade 
"Change in wt ~ FFA: final value minus cont rol period 
value: mean ± SEM 
~ Final value minus cont rol period value : mean ± SEM 
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not a lower post·treatment ratio. When individual 
subjects were analyzed fo r a correlation between a 
change in acne severity and a decrease in FFArrG 
ratio, none of the correlations even approached 
statistical significance. 
The data in Table II are the average changes in 
the t reatment groups and thus may mask correla -
tions between changes in acne severity and 
changes in su rface lipid FFA conten t. We. there· 
fore, have determined t he changes in FFA content 
(weight percent) and concentration (mg per unit 
area of skin) in subjects from all groups who 
showed a decrease in severity (> 1 uni i). a slight 
decrease « 1 unit). and no decrease or an increase 
in severity (Tab. IV ). The resul ts show that the 
change in FF A content and concentration were 
similar in all groups and that the varia t ion among 
subjects within each group was alm ost as great as 
the mean change. 
The data above show t hat no change in surface 
lipid mass. FFA conteni, or FFArrC ratio was 
observed that could be associated with a change in 
acne severity in the subjects studied. In order to 
assess whether changes occurred in other surface 
lipid components. all of t he samples of surface 
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176 ANDERSON. COOK. AND SMITH Vol. 66. No.3 
Topical Tetracycl i ne 
100 
Sq' He . . 
--.-.---. " .- .... -.-. .-.-.-.-..... . .......... , ......... ".-......... , . .... / '.- ...... . . 
~75 
::i 'WE 
. /\ ., . .-...... ·'V'·~>,. \f:-:':: <.> --. / ...... '·,1.-.... . ',/\ "/ 'Of'\. ~50 S"Jjj' " ,,'-. \ \~.</\. .,./to_. .. 
...-.... Go' .. " ' j . ': :::> ". . . (/) . . 
.... 
0 
~ 25 TG - / .... 0 
'.- ..... 
~ ....... -.-.-. " 
., I·' /-.... ' ./ ._.-.--
FFA . . ...... " ..... "' ..... 
"' __ to __ 
0 
6 '-, 
.-. 
., \ \/V\ \_ . '"' ... -. .., ~4 .-. \F' (!) \ ''/ ~ . \ '-..-.0= 2 ' . .-. ., , > 
" ., 
. (/) , 
0 123456 123456 12 3456 123456 123456 12345 6 
B Assay Number 
Flc. 2. B 
lipids frQm 6 subjects treated with lOpicai tetracy-
cline and 6 subjects treated with oral tetracycline 
were examined by semiquantitative TLC ( Fig. 2). 
In these 12 subjects there "'ere no chang-es in any 
surface lipid component that could be correlated 
with changes in acne severity. That is, the compo-
sition of the surface lipids of each individual was 
constant whether the subject showed marked 
chan~es in acne severity or not. These results also 
show that init ial acne severity grade does not seem 
to be related to the FFA content of the skin surface 
lipids. 
DISCUSSIOK 
The pu rpose of this investigation was to compa re 
chanJ{es in acne severity to changes in cheek SU T# 
face lipid composition . Data presented show that 
both oral and topical tetracycline caused a signifi ~ 
cant decrease in acne severit y while the placebo 
treatment did not. Thus. we feel that we had a 
legitimate study in wh ich to compa re the changes 
in surface lipids with changes in acne severi ty. 
The results of this work dem onstrate that treat -
ment for 8 weeks with 500 mg of tetracycline per 
day did not signifi cantly reduce the FFA of the 
skin surface lipids. This appears to be at odds with 
data reponed by Beveridge and Powell [7 J. Mar-
ples et al [8 J. and Gloor et al [1 3J. all of whom 
report a decrease in surface lipid FFA concentra -
tions with oral tetracycline. There a re. however. 
several differences in the treatments among: these 
studies . For example. Beverid~e and Powell Ii ! 
sa mpled the forehead. Ma rpl es et al [81 the scalp. 
Gloor et al !1 3J the back. and we have examined 
the cheek. 1t is well docilmented t hat the FFA of 
su rface lipids vary greatly at different siles on the 
body [171. 
Another difference between our work and at least 
that of Beveridge and Powell [Iii and Gloor et a l 
[131 is that our surface lipid samp les were casual 
samples. whereas these other authors used timed 
collections. Gloor et al [11! have reported. how-
ever. that topica l t reatment with Scr, tetracycline 
reduces t he FFArrG ratio in su rface lipids of both 
casual samples and timed collections of surface 
lipids. 
The differences in results obtained in ou r work 
and that of ot hers may also involve th e severity of 
the acne of the subjects. In our work we have 
examined a cross-section of a high-school-age 
group ; we had very few subjects with severe acne 
(> 6 grade units) and the majority were in the 2 to 
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4 grade unit range. We cannot tell how these 
subjects compare to those used in other studies. 
When subjects were treated with tetracycline 
topically, essentially no decrease in FFA concentra· 
tion in t he skin surface lipids was observed . This 
was an unexpected result since we had expected 
topical treatment to maximize the effect of tetra· 
cycline on skin flora and to reduce or inhibit 
bacterial lipase [18[. We have no ready ex plana . 
tion for the lack of effect of topical tetracycline on 
su rface lipid composition, especially since other 
workers [9-11 J have reported that antibiotics ap-
plied to pically do reduce the FFA concentration in 
skin su rface lipids. It is possible thaI the time 
between the last topical teLrac~tcline treatment 
and lipid sa mplin g (-18 hrl in our study was 
sufficient to allow lipolysis to recover. It is un* 
likely, however, that in all samples one would get 
recovery to the pretreatment value of FFA (Tab. 
II ). It is also unlikely that if tetracycline were 
reducing the numbers of lipol~·tic bacteria 18] or 
inhibiting bacterial lipase 118], such treatment 
following 8 weeks of topical applica tion would not 
have resulted in a measurable decrease in FF A 
concentration of the casual surface lipids. 
Part of the objective of thi s work was to assess 
t he effect of acne the rapy on surface lipid composi· 
tion and to test the hypot hesis that acne is caused 
by FFA produced from sebum triglycerides by 
ba cterial lipase [5J. While the data obtained do nOt 
negate this hypothesis. they do show that allevia* 
tion of acne by tetracycline need not be accompa* 
nied by a detectable decrease in surface lipid FF A 
levels of FFArrG ratio. In fact. it was unexpected 
that t.opical tetracycline. whi ch should have opti· 
mized the tetracycli ne effect against su rface flora. 
had less effect on surface lipid FFA than oral 
tetrac~'cli ne and yet the IwO treatment.s resulted in 
comparable reductions in acne severity. Thus. we 
would conclude that while FFA ma~' be a causative 
agent in acne etiology. this effect ca nnot be ascer-
tained b~' measu ring casual surface lipid FFA 
levels. 
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